167 related articles for article (PubMed ID: 6146241)
1. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits--influences of selective blocking drugs.
Knudtzon J
Acta Physiol Scand; 1984 Mar; 120(3):353-61. PubMed ID: 6146241
[TBL] [Abstract][Full Text] [Related]
2. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
Knudtzon J
Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
[TBL] [Abstract][Full Text] [Related]
3. Alpha-melanocyte stimulating hormone increases plasma levels of glucagon and insulin in rabbits.
Knudtzon J
Life Sci; 1984 Feb; 34(6):547-54. PubMed ID: 6141515
[TBL] [Abstract][Full Text] [Related]
4. Acute in-vivo effects of adrenocorticotrophin on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits: involvement of the alpha-adrenergic nervous system.
Knudtzon J
J Endocrinol; 1984 Mar; 100(3):345-52. PubMed ID: 6321628
[TBL] [Abstract][Full Text] [Related]
5. Insulin secretion and glucose kinetics during exercise with and without pharmacological alpha(1)- and alpha(2)-receptor blockade.
Aarnio P; Lauritsen T; Dela F
Diabetes; 2001 Aug; 50(8):1834-43. PubMed ID: 11473046
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the autonomic nervous system in the in vivo TRH-induced increases in the plasma levels of glucagon, insulin and glucose in rabbits.
Knudtzon J
Horm Metab Res; 1985 Feb; 17(2):53-7. PubMed ID: 3921449
[TBL] [Abstract][Full Text] [Related]
7. Effects of the beta 3-adrenoceptor agonist BRL 37344 on lipomobilization and plasma glucose levels in conscious fasted rabbits.
Reverte M; Rivas-Cabañero L
Can J Physiol Pharmacol; 1996 Mar; 74(3):251-6. PubMed ID: 8773403
[TBL] [Abstract][Full Text] [Related]
8. Differential role of adrenoceptors in control of plasma glucose and fatty acids in carp, Cyprinus carpio (L.).
van den Thillart G; Vianen G; Ponce MC; Lelieveld H; Nieveen M; Van Raaij M; Steffens A; Zaagsma J
Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R615-24. PubMed ID: 11448867
[TBL] [Abstract][Full Text] [Related]
9. The integrated effect of adrenergic blockade on glucose, fatty acid, and glycerol kinetics: responses in the basal state and during hormonal control with somatostatin-hormonal infusion.
Shaw JH; Wolfe RR
J Surg Res; 1987 Mar; 42(3):257-72. PubMed ID: 2881026
[TBL] [Abstract][Full Text] [Related]
10. The role of adrenergic receptors in the increased glucose uptake by the canine gut.
Alada AR; Oyebola DD
Afr J Med Med Sci; 1997; 26(1-2):75-8. PubMed ID: 10895237
[TBL] [Abstract][Full Text] [Related]
11. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
Knudtzon J
Horm Metab Res; 1981 Jul; 13(7):371-5. PubMed ID: 6792023
[TBL] [Abstract][Full Text] [Related]
13. Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics.
Viberti GC; Keen H; Bloom SR
Metabolism; 1980 Sep; 29(9):873-9. PubMed ID: 6106149
[TBL] [Abstract][Full Text] [Related]
14. The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists.
Abdel-Zaher AO; Ahmed IT; El-Koussi AD
Pharmacol Res; 2001 Nov; 44(5):397-409. PubMed ID: 11712871
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation.
Raptis S; Escobar-Jimenez F; Rosenthal J; Ditschuneit HH; Pfeiffer EF
J Clin Endocrinol Metab; 1977 Jun; 44(6):1088-93. PubMed ID: 874045
[TBL] [Abstract][Full Text] [Related]
16. Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration.
William-Olsson T; Fellenius E; Björntorp P; Smith U
Acta Med Scand; 1979; 205(3):201-6. PubMed ID: 218427
[TBL] [Abstract][Full Text] [Related]
17. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
[TBL] [Abstract][Full Text] [Related]
18. Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms.
Kraenzlin ME; Keller U; Keller A; Thélin A; Arnaud MJ; Stauffacher W
J Clin Invest; 1989 Aug; 84(2):388-93. PubMed ID: 2569473
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
Smith HJ; Halliday SE; Earl DC; Stribling D
J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of insulin secretion during selective blockade of alpha 1- and alpha 2-adrenoceptors in the rat: effects of somatostatin.
Ahrén B; Järhult J; Lundquist I
Acta Physiol Scand; 1982 Jun; 115(2):257-60. PubMed ID: 6127872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
